As of 2025-07-06, the Net Margin of Epigenomics AG (ECX.DE) is -2479.2%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2022-12-31 | -2479.2% |
2021-12-31 | -39.1% |
2020-12-31 | -1387.9% |
- | |
- | |
- | |
- | |
- | |
- | |
- |